Ann: ResApp Receives Notice of Allowance for Core Patent in Japan, page-71

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 71 Last

Share
Profile

Follow
mumstheword

2,528 Posts.

272

13/11/18

03:28

Post #: 36478405
Share

Originally posted by TerribleTadpole ↑

Originally posted by Sonny87
Hey TT,

Thanks for the considered response. I agree management could have done a better job communicating the difficulties that the US Healthcare system and approach to diagnosis posed to their study. I also think they could have done abetter job communicating which disease endpoints represented the biggest market opportunities. For me there was too much of a focus on pneumonia when pneumonia is much more prevalent in developing nations and not the market for telehealth providers. I spoke to management after the Techknow conference and expressed these views and I also followed up with an email. You are also entitled to express your views to management and I would encourage you to do that. It provides meaningful feedback to the company that they can respond to as opposed to spreading discontent in online forums which really benefits no one.

The company is required to be honest in its disclosures to the market and I think they have been. They honestly believe the latest US results demonstrate their world leading innovation in respiratory diagnosis is valuable to medical professionals. You and many others disagree. However based on the weight of evidence I still think they are correct.

The upcoming CE application, based on the outstanding Australian results, may make a few reconsider. A quick google search puts the European telehealth market at 3.1 billion in 2016 and is expected to reach USD 18.3 billion by 2024 (https://www.marketwatch.com/press-r...are-solutions-mckesson-corporation-2018-03-15).
Resapp are positioning themselves to take a share of that.

Cheers,

Also I can't find the quote "which serves to strengthen the expectation
that the US and Australian results will be similar
" in the End of Year Report or 3rd September announcement. If you can point me in the direction of it that would be helpful, for my own piece of mind.

The phrase "which serves to strengthen the expectation..." isn't a quote from an announcement. I used italics and underline for emphasis, which was a confusing thing to do because that's commonly used for quoting on the forum. Sorry. My point was that both of those announcements refer to the Australian results and then immediately discuss the upcoming US results, thus connecting the two sets of results and creating said expectation.

Expand

Good morning TT. I feel I owe you an apology for a smart-@rse below the belt post - rre what flicks off that brush. I wish to apologise to you publicly in the interest of fair-play, that this forum is a good place, where we can come and have respected opinions and healthy argument on any subject. I apologise.

RAP Price at posting: 10.0¢ Sentiment: Buy Disclosure: Held
15 Upvote

0 Great analysis

Reply

Top Stories

SBW

Shekel Brainweigh investor presentation webinar – the future of retail automation

QML

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

CBA breaks trading record on strong day for Aussie financials

RMX

Red Mountain Mining: record gold prices, two projects, two greenstone belts

BIT

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

PRU

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

OCC

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

As Nvidia cools, we're looking to Aussie AI

LAM

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

There are more pages in this discussion • 21 more messages in this thread...

First 71 Last

Add RAP (ASX) to my watchlist

Ann: ResApp Receives Notice of Allowance for Core Patent in Japan, page-71

Top Stories

Shekel Brainweigh investor presentation webinar – the future of retail automation

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

CBA breaks trading record on strong day for Aussie financials

Red Mountain Mining: record gold prices, two projects, two greenstone belts

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

As Nvidia cools, we're looking to Aussie AI

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

Featured News